M.K. Tuut

567 total citations
25 papers, 429 citations indexed

About

M.K. Tuut is a scholar working on Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, M.K. Tuut has authored 25 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Physiology. Recurrent topics in M.K. Tuut's work include Clinical practice guidelines implementation (11 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Breast Cancer Treatment Studies (4 papers). M.K. Tuut is often cited by papers focused on Clinical practice guidelines implementation (11 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Breast Cancer Treatment Studies (4 papers). M.K. Tuut collaborates with scholars based in Netherlands, Switzerland and Germany. M.K. Tuut's co-authors include Victoria Pennick, Claire Bombardier, Maurits W. van Tulder, Willem JJ Assendelft, Emiel J. Rutgers, Geertjan van Tienhoven, M. Limburg, J.W.R. Nortier, Phyllis I. Spuls and M. Bontenbal and has published in prestigious journals such as Spine, Journal of Clinical Epidemiology and BMC Medical Research Methodology.

In The Last Decade

M.K. Tuut

23 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.K. Tuut Netherlands 12 110 97 94 88 76 25 429
Zhuo Yang United States 15 128 1.2× 133 1.4× 49 0.5× 102 1.2× 30 0.4× 22 692
Moreno Zanardo Italy 17 50 0.5× 65 0.7× 30 0.3× 76 0.9× 131 1.7× 52 760
Valeria Manicardi Italy 16 67 0.6× 33 0.3× 22 0.2× 31 0.4× 64 0.8× 48 868
Marian Wald Myers United States 9 89 0.8× 94 1.0× 52 0.6× 15 0.2× 73 1.0× 15 746
Shahnaz Khan United States 14 93 0.8× 52 0.5× 25 0.3× 12 0.1× 68 0.9× 30 816
N. Scorpiglione Italy 13 38 0.3× 19 0.2× 51 0.5× 60 0.7× 96 1.3× 16 484
Sean Skeldon Canada 12 31 0.3× 65 0.7× 57 0.6× 36 0.4× 76 1.0× 20 636
Danielle S. Chun United States 13 58 0.5× 154 1.6× 47 0.5× 19 0.2× 27 0.4× 33 678
Luqin Deng United States 18 67 0.6× 21 0.2× 19 0.2× 94 1.1× 115 1.5× 55 944
Artitaya Lophatananon United Kingdom 16 54 0.5× 35 0.4× 18 0.2× 95 1.1× 140 1.8× 46 682

Countries citing papers authored by M.K. Tuut

Since Specialization
Citations

This map shows the geographic impact of M.K. Tuut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.K. Tuut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.K. Tuut more than expected).

Fields of papers citing papers by M.K. Tuut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.K. Tuut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.K. Tuut. The network helps show where M.K. Tuut may publish in the future.

Co-authorship network of co-authors of M.K. Tuut

This figure shows the co-authorship network connecting the top 25 collaborators of M.K. Tuut. A scholar is included among the top collaborators of M.K. Tuut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.K. Tuut. M.K. Tuut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuut, M.K., et al.. (2024). Required knowledge for guideline panel members to develop healthcare related testing recommendations: a developmental study. Journal of Clinical Epidemiology. 173. 111438–111438. 1 indexed citations
2.
Tuut, M.K., Gowri Gopalakrishna, Mariska Leeflang, et al.. (2024). Co-creation of a step-by-step guide for specifying the test-management pathway to formulate focused guideline questions about healthcare related tests. BMC Medical Research Methodology. 24(1). 241–241.
3.
Tuut, M.K., et al.. (2020). Applying GRADE for diagnosis revealed methodological challenges: an illustrative example for guideline developers. Journal of Clinical Epidemiology. 131. 123–132. 4 indexed citations
4.
Hemmelder, Marc H., et al.. (2018). Herziening richtlijnen ‘Chronische nierschade’. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 162.
6.
Tuut, M.K., et al.. (2015). [The NHG guidelines 'Adult asthma' and 'COPD'].. PubMed. 159. A9076–A9076. 10 indexed citations
7.
Smeele, Ivo, Berna DL Broekhuizen, Niels H. Chavannes, et al.. (2015). NHG-Standaard Astma bij volwassenen (derde herziening). Radboud Repository (Radboud University). 58(3). 142–154. 6 indexed citations
8.
Bindels, Patrick, et al.. (2014). [Dutch College of General Practitioners' practice guideline 'Asthma in children'].. PubMed. 158. A7935–A7935. 3 indexed citations
9.
Hoorn, Ewout J., et al.. (2013). Dutch guideline for the management of electrolyte disorders--2012 revision.. PubMed. 71(3). 153–65. 14 indexed citations
10.
Tuut, M.K., et al.. (2011). Prospective comparison of three guideline development methods for treatment of actinic keratosis. BMJ Quality & Safety. 20(10). 832–841. 5 indexed citations
11.
Tuut, M.K., Gerard J. den Heeten, Christi J. van Asperen, et al.. (2008). [Revised practice guideline 'Screening and diagnosis of breast cancer'].. PubMed. 152(43). 2336–9. 6 indexed citations
12.
Dekhuijzen, P. N. Richard, M.E.A.C. Broeders, M.K. Tuut, & M H Grol. (2008). [Practice guideline 'Medical treatment of COPD'].. PubMed. 152(26). 1465–8. 2 indexed citations
13.
Koes, Bart W., et al.. (2004). [The Dutch Institute for Health Care Improvement (CBO) guideline for the diagnosis and treatment of aspecific acute and chronic low back complaints].. PubMed. 148(7). 310–4. 17 indexed citations
14.
Tulder, Maurits W. van, M.K. Tuut, Victoria Pennick, Claire Bombardier, & Willem JJ Assendelft. (2004). Quality of Primary Care Guidelines for Acute Low Back Pain. Spine. 29(17). E357–E362. 116 indexed citations
15.
Spuls, Phyllis I., M.K. Tuut, J.J.E. van Everdingen, & Menno A. de Rie. (2004). [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].. PubMed. 148(43). 2121–5. 29 indexed citations
16.
Rutgers, Emiel J., J.W.R. Nortier, M.K. Tuut, et al.. (2002). CBO-richtlijn 'behandeling van het mammacarcinoom'. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 146(45). 2144–2151. 38 indexed citations
17.
Tuut, M.K., et al.. (2001). [CBO guideline 'High blood pressure' (revision)].. PubMed. 145(43). 2071–6. 13 indexed citations
18.
Tuut, M.K.. (2001). Smoking, Other Risk Factors and Fibrinogen Levels Evidence of Effect Modification. Annals of Epidemiology. 11(4). 232–238. 43 indexed citations
19.
Rutgers, Emiel J. & M.K. Tuut. (2001). [CBO guideline 'Breast cancer: screening and diagnosis'].. PubMed. 145(3). 115–9. 5 indexed citations
20.
Limburg, M. & M.K. Tuut. (2000). [CBO guideline 'Stroke' (revision) Dutch Institute for Healthcare Improvement].. PubMed. 144(22). 1058–62. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026